| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 725,912 | 749,887 | 823,325 | 989,837 | | Cost of Revenue | 459,501 | 484,830 | 529,597 | 587,451 | | | Gross Profit | 266,411 | 265,057 | 293,728 | 402,386 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 248,870 | 255,007 | 277,050 | 334,895 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 281 | 280 | 618 | 740 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 17,260 | 9,770 | 16,060 | 66,751 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 159 | 455 | 620 | 323 | | Earnings Before Interest And Taxes | 17,419 | 10,225 | 16,680 | 67,074 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 17,419 | 10,225 | 16,680 | 67,074 | | Income Tax Expense | 7,888 | 4,809 | 7,892 | 28,066 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 9,531 | 5,416 | 8,788 | 39,008 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 9,531 | 5,416 | 8,788 | 39,008 | | Preferred Stock And Other Adjustments | (543) | (1,094) |
-
|
-
| | | Net Income Applicable To Common Shares | $8,988 | $4,322 | $8,788 | $39,008 |
|
0.31% Nasdaq 0.00%
Income Statement
